Dear NMusers,

A 4-day Advanced PK/PD Modeling Methodology using Phoenix WinNonlin training 
course will be given on August 22-25, 2011 at the Hilton San Francisco 
Fisherman's Wharf, 
www.hiltonfishermanswharf.com<http://www.hiltonfishermanswharf.com/>.


This advanced workshop provides an interface between analysis and modeling of 
PK/PD data, physiological concepts, and applications to drug development and 
improved pharmacotherapy. The course is a combination of lectures to provide 
background concepts and hands-on exercises using Phoenix WinNonlin.

For more information and to register, please visit 
http://www.pharsight.com/training/course_display_new.php?details_id=73

This is a public course organized by Pharsight Corporation.  If required,  free 
software licenses for the course will be provided.

Pharsight Corporation reserves the right to cancel the course if the minimum 
number of registrants is not met by July 23, 2011.

COURSE INSTRUCTOR

Dr. Daniel L. Weiner is the Senior Vice President and General Manager of 
Software at Pharsight Corporation, a Certara Company. He has presented numerous 
workshops on the statistical evaluation of pharmacokinetic and bioavailability 
data for over 20 years and has served as an expert advisor to the FDA.  He is 
also the co-author of "Pharmacokinetic and Pharmacodynamic Data Analysis: 
Concepts and Applications", 4th ed.



Best regards,



Li


_________________________________________________________________
NOTICE: The information contained in this electronic mail message is intended 
only for the personal and confidential use of the designated recipient(s) named 
above. This message may be an attorney-client communication, may be protected 
by the work product doctrine, and may be subject to a protective order. As 
such, this message is privileged and confidential. If the reader of this 
message is not the intended recipient or an agent responsible for delivering it 
to the intended recipient, you are hereby notified that you have received this 
message in error and that any review, dissemination, distribution, or copying 
of this message is strictly prohibited. If you have received this communication 
in error, please notify us immediately by telephone and e-mail and destroy any 
and all copies of this message in your possession (whether hard copies or 
electronically stored copies). Thank you.

Reply via email to